Animal Healthcare Market (By Animal Type: Production Animal, Companion Animal; By Product: Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Equipment and Disposables; By Distribution Channel: Retail Pharmacy, E-commerce, Hospital Pharmacy; By End Use; By Treatments)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Animal Healthcare market size was estimated at USD 53.20 billion in 2021 and is expected to surpass around USD 77.12 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period 2022 to 2030. Increase in animal population, high prevalence of diseases, and surge in global consumption of meat and milk are projected to drive the global animal healthcare market during the forecast period

Rise in Prevalence of Diseases in Animals and Increase in Global Consumption of Meat & Milk: Key Drivers

• Increase in global consumption of meat and milk, new diseases in animals, and their transfer to humans via product consumption and companionship drive the global animal healthcare market. Changing lifestyle, increase in per-capita income, and surge in population have led to a rise in meat consumption globally. Demand for protein rich food such as meat, eggs, and milk is rising. This increases the number of animal farms globally. The healthcare expenditure in farms is rising due to surge in number of animals and growing concern about their health.
• According to the European Food Safety Authority (EFSA), around 320,000 cases of food-borne and zoonotic diseases are reported each year in the European Union. Campylobacteriosis was the most-commonly observed zoonoses in animals, which affected 220,209 people in 2012 in the European Union (EU) countries due to the consumption of infected broiler meat.

Report Scope of the Animal Healthcare Market

Advancement in Technology Leading to Easy Usage Boosts Market Growth

• The animal health industry is currently thriving due to technical breakthroughs and increase in research & development operations in the veterinary pharmaceutical business. Data generated in veterinary clinics can now be uploaded to the Internet, and shared with other academics and physicians attributed to new technology tools. This technology also assists in the investigation of changes in disease prevalence in real time. Governments in numerous industrialized nations are also pursuing projects and implementing animal immunization programs in order to improve the veterinary healthcare industry.

Stringent Regulations and High Cost of Animal Healthcare Services to Hamper Market

• Some challenges have emerged in the form of regulations against the excess use of antibiotics in production animals and protest of animal activists and institutions against animal research. Antibiotics are used in animals for therapeutic and non-therapeutic purposes, including their growth promotion. However, excessive use of antibiotics in animals has been affecting the health of people consuming their products. This has led to serious concerns within regulatory authorities globally who have started imposing restrictions on the use of antibiotics in production animals.

Emergence of New Disease Conditions Contributing to Market Growth

There are several new diseases that are affecting animals these days. These diseases can either make the animal seriously ill or can even kill them. It is, therefore, necessary for the animals’ owner to have necessary medications to cure the animals. Moreover, the emergence of such diseases has heightened the need for veterinary clinics to be located close to animal husbandries or farms. This is also a major factor that is boosting the growth of the global animal healthcare market during the years 2021 to 2028.

Stakeholders Ensure Robust Supply of Life-saving Therapeutics During COVID-19 Pandemic

Veterinarians in the market for animal healthcare have been striving to meet urgent care needs of companion and production animals during the ongoing COVID-19 pandemic. Since veterinarians are at a high risk of exposure to the novel infection, these practitioners are indefinitely postponing elective animal treatment procedures. Such trends are resulting in an impetus to the telehealth and eHealth app sector. At the same time, participants in the market are ensuring robust supply of life-saving therapeutics, animal feed additives, and vaccines to prevent interruptions in treatment procedures. Domestic and global companies are in the midst of rapid shift in supply chain planning, operations, and inventory management to address the impact of the pandemic.

NGOs Hamper Market Growth by Raising Concerns over Animal Drug Testing

There are several non-government organizations (NGOs) that are actively opposing pharmaceutical companies and research organizations that are using live animals as their test subjects. These organizations are one of the major reasons that are boosting the growth of the global animal healthcare market during the projected period. However, due to these oppositions, pharmaceutical companies are not able to develop drugs that can help the animals to regain their deteriorating health. This might act as growth hampering factor for the global animal healthcare market. Nevertheless, companies have started to examine the animals’ health via several survey and are collecting data from pet owners to innovate in new drugs. This data can help the market players to derive effective drug and therapeutic formulations for the animals. As a result of this development, the global animal healthcare market is projected to sustain its growth momentum over the assessment period.

Innovations in Vaccines Hold Potentials to Offer Protection against Several Diseases

Vaccination is the best protection that any animal owner can provide to its pet or production animal. These vaccines improves the immunity of the animal against several diseases. This is the reason that the segment is witnessing massive investments by pharmaceutical companies. The companies are investing a fortune to develop new vaccines that can protect the animals from diseases such as hepatitis, cholera, and other viral & bacterial diseases in the future.

Investment in Animal Healthcare Budgets Creating Lucrative Opportunities in North America

The animal healthcare market is dominated by North America in terms of revenue. The region is witnessing massive growth in the demand for better healthcare services in countries such as the U.S. and Canada. These countries are investing a massive amount in their annual budget to offer better healthcare service in the upcoming years. Due to these reasons, the global animal healthcare market is expected to be dominated by North America on regional front throughout the assessment period.

Animal husbandry and agriculture are two of the most important industries influencing the economy of any country. It is, therefore, essential for the farmers and industry owners to ensure that their animals are in good health and in good shape. Due to this growing awareness of animal health, the global animal healthcare market is projected to grow substantially in the upcoming years.

Some of the prominent players in the Animal Healthcare Market include:

• Elanco
• Bayer
• Dechra Pharmaceuticals
• Neogen
• Boehringer Ingelheim
• Merck & Co, Inc.
• Zoetis
• Nutreco N.V.
• Virbac
• Vetquinol S.A.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Animal Healthcare market

By Animal Type

• Production Animal
• Poultry
• Swine
• Cattle
• Fish
• Others
• Companion Animal
• Dogs
• Cats
• Horses
• Others

By Product

• Vaccines
• Live Attenuated Vaccines
• DNA Vaccines
• Recombinant Vaccines
• Inactivated Vaccines
• Others
• Pharmaceuticals
• Parasiticides
• Anti-infective
• Anti-inflammatory
• Analgesics
• Others
• Feed Additives
• Diagnostics
• Instruments
• Consumables
• Equipment and Disposables
• Critical Care Consumables
• Anesthesia Equipment
• Fluid Management Equipment
• Temperature Management Equipment
• Rescue & Resuscitation Equipment
• Research Equipment
• Patient Monitoring Equipment
• Others
• Veterinary Telehealth
• Veterinary Software
• Livestock Monitoring

By Distribution Channel

• Retail Pharmacy
• E-commerce
• Hospital Pharmacy

By End Use

• Reference Laboratories
• Point of care testing/ in-house testing
• Veterinary Hospitals & Clinics 
• Others

By Treatments

• Allergies
• Arthritis
• Difficult Dermatology Cases
• Gastrointestinal Disease
• Others

By Regional Outlook

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Animal Healthcare industry analysis from 2022 to 2030 to identify the prevailing Animal Healthcare industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Animal Healthcare industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

•  

  Chapter 1. Introduction

  1.1. Research Objective

  1.2. Scope of the Study

  1.3. Definition

  Chapter 2. Research Methodology

  2.1. Research Approach

  2.2. Data Sources

  2.3. Assumptions & Limitations

  Chapter 3. Executive Summary

  3.1. Market Snapshot

  Chapter 4. Market Variables and Scope 

  4.1. Introduction

  4.2. Market Classification and Scope

  4.3. Industry Value Chain Analysis

  4.3.1. Raw Material Procurement Analysis 

  4.3.2. Sales and Distribution Channel Analysis

  4.3.3. Downstream Buyer Analysis

  Chapter 5. COVID 19 Impact on Animal Healthcare Market 

  5.1. COVID-19 Landscape: Animal Healthcare Industry Impact

  5.2. COVID 19 - Impact Assessment for the Industry

  5.3. COVID 19 Impact: Global Major Government Policy

  5.4. Market Trends and Opportunities in the COVID-19 Landscape

  Chapter 6. Market Dynamics Analysis and Trends

  6.1. Market Dynamics

  6.1.1. Market Drivers

  6.1.2. Market Restraints

  6.1.3. Market Opportunities

  6.2. Porter’s Five Forces Analysis

  6.2.1. Bargaining power of suppliers

  6.2.2. Bargaining power of buyers

  6.2.3. Threat of substitute

  6.2.4. Threat of new entrants

  6.2.5. Degree of competition

  Chapter 7. Competitive Landscape

  7.1.1. Company Market Share/Positioning Analysis

  7.1.2. Key Strategies Adopted by Players

  7.1.3. Vendor Landscape

  7.1.3.1. List of Suppliers

  7.1.3.2. List of Buyers

  Chapter 8. Global Animal Healthcare Market, By Animal Type

  8.1. Animal Healthcare Market, by Animal Type, 2022-2030

  8.1.1. Production Animal

  8.1.1.1. Market Revenue and Forecast (2017-2030)

  8.1.2. Companion Animal

  8.1.2.1. Market Revenue and Forecast (2017-2030)

  Chapter 9. Global Animal Healthcare Market, By Product Type

  9.1. Animal Healthcare Market, by Product Type, 2022-2030

  9.1.1. Vaccines

  9.1.1.1. Market Revenue and Forecast (2017-2030)

  9.1.2. Pharmaceuticals

  9.1.2.1. Market Revenue and Forecast (2017-2030)

  9.1.3. Feed Additives

  9.1.3.1. Market Revenue and Forecast (2017-2030)

  9.1.4. Diagnostics

  9.1.4.1. Market Revenue and Forecast (2017-2030)

  9.1.5. Equipment and Disposables

  9.1.5.1. Market Revenue and Forecast (2017-2030)

  9.1.6. Others

  9.1.6.1. Market Revenue and Forecast (2017-2030)

  Chapter 10. Global Animal Healthcare Market, By Distribution Channel

  10.1. Animal Healthcare Market, by Distribution Channel Type, 2022-2030

  10.1.1. Retail Pharmacy

  10.1.1.1. Market Revenue and Forecast (2017-2030)

  10.1.2. E-commerce

  10.1.2.1. Market Revenue and Forecast (2017-2030)

  10.1.3. Hospital Pharmacy

  10.1.3.1. Market Revenue and Forecast (2017-2030)

  Chapter 11. Global Animal Healthcare Market, By End Use

  11.1. Animal Healthcare Market, by End Use Type, 2022-2030

  11.1.1. Reference Laboratories

  11.1.1.1. Market Revenue and Forecast (2017-2030)

  11.1.2. Point of care testing/ in-house testing

  11.1.2.1. Market Revenue and Forecast (2017-2030)

  11.1.3. Veterinary Hospitals & Clinics

  11.1.3.1. Market Revenue and Forecast (2017-2030)

  11.1.4. Others

  11.1.4.1. Market Revenue and Forecast (2017-2030)

  Chapter 12. Global Animal Healthcare Market, By Treatments Type

  12.1. Animal Healthcare Market, by Treatments, 2022-2030

  12.1.1. Allergies

  12.1.1.1. Market Revenue and Forecast (2017-2030)

  12.1.2. Arthritis

  12.1.2.1. Market Revenue and Forecast (2017-2030)

  12.1.3. Gastrointestinal Disease

  12.1.3.1. Market Revenue and Forecast (2017-2030)

  12.1.4. Difficult Dermatology Cases

  12.1.4.1. Market Revenue and Forecast (2017-2030)

  12.1.5. Others

  12.1.5.1. Market Revenue and Forecast (2017-2030)

  Chapter 13. Global Animal Healthcare  Market, Regional Estimates and Trend Forecast

  13.1. North America

  13.1.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.1.2. Market Revenue and Forecast, by Product (2017-2030)

  13.1.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.1.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.1.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.1.6. U.S.

  13.1.6.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

  13.1.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.1.7. Market Revenue and Forecast, by Treatments (2017-2030) 

  13.1.8. Rest of North America

  13.1.8.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)

  13.1.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.1.8.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.1.8.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.2. Europe

  13.2.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.2.2. Market Revenue and Forecast, by Product (2017-2030)

  13.2.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.2.4. Market Revenue and Forecast, by End Use (2017-2030) 

  13.2.5. Market Revenue and Forecast, by Treatments (2017-2030) 

  13.2.6. UK

  13.2.6.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

  13.2.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.2.7. Market Revenue and Forecast, by End Use (2017-2030) 

  13.2.8. Market Revenue and Forecast, by Treatments (2017-2030) 

  13.2.9. Germany

  13.2.9.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

  13.2.9.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.2.10. Market Revenue and Forecast, by End Use (2017-2030)

  13.2.11. Market Revenue and Forecast, by Treatments (2017-2030)

  13.2.12. France

  13.2.12.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

  13.2.12.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.2.12.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.2.13. Market Revenue and Forecast, by Treatments (2017-2030)

  13.2.14. Rest of Europe

  13.2.14.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

  13.2.14.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.2.14.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.2.15. Market Revenue and Forecast, by Treatments (2017-2030)

  13.3. APAC

  13.3.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.3.2. Market Revenue and Forecast, by Product (2017-2030)

  13.3.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.3.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.3.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.3.6. India

  13.3.6.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

  13.3.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.3.7. Market Revenue and Forecast, by Treatments (2017-2030)

  13.3.8. China

  13.3.8.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

  13.3.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.3.9. Market Revenue and Forecast, by Treatments (2017-2030)

  13.3.10. Japan

  13.3.10.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

  13.3.10.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.3.10.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.3.10.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.3.11. Rest of APAC

  13.3.11.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

  13.3.11.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.3.11.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.3.11.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.4. MEA

  13.4.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.4.2. Market Revenue and Forecast, by Product (2017-2030)

  13.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.4.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.4.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.4.6. GCC

  13.4.6.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

  13.4.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.4.7. Market Revenue and Forecast, by Treatments (2017-2030)

  13.4.8. North Africa

  13.4.8.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

  13.4.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.4.9. Market Revenue and Forecast, by Treatments (2017-2030)

  13.4.10. South Africa

  13.4.10.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

  13.4.10.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.4.10.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.4.10.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.4.11. Rest of MEA

  13.4.11.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

  13.4.11.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.4.11.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.4.11.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.5. Latin America

  13.5.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.5.2. Market Revenue and Forecast, by Product (2017-2030)

  13.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.5.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.5.5. Market Revenue and Forecast, by Treatments (2017-2030)

  13.5.6. Brazil

  13.5.6.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

  13.5.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.5.7. Market Revenue and Forecast, by Treatments (2017-2030)

  13.5.8. Rest of LATAM

  13.5.8.1. Market Revenue and Forecast, by Animal (2017-2030)

  13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

  13.5.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

  13.5.8.4. Market Revenue and Forecast, by End Use (2017-2030)

  13.5.8.5. Market Revenue and Forecast, by Treatments (2017-2030)

  Chapter 14. Company Profiles

  14.1. Elanco

  14.1.1. Company Overview

  14.1.2. Product Offerings

  14.1.3. Financial Performance

  14.1.4. Recent Initiatives

  14.2. Bayer

  14.2.1. Company Overview

  14.2.2. Product Offerings

  14.2.3. Financial Performance

  14.2.4. Recent Initiatives

  14.3. Dechra Pharmaceuticals

  14.3.1. Company Overview

  14.3.2. Product Offerings

  14.3.3. Financial Performance

  14.3.4. Recent Initiatives

  14.4. Neogen

  14.4.1. Company Overview

  14.4.2. Product Offerings

  14.4.3. Financial Performance

  14.4.4. Recent Initiatives

  14.5. Boehringer Ingelheim

  14.5.1. Company Overview

  14.5.2. Product Offerings

  14.5.3. Financial Performance

  14.5.4. Recent Initiatives

  14.6. Merck & Co, Inc.

  14.6.1. Company Overview

  14.6.2. Product Offerings

  14.6.3. Financial Performance

  14.6.4. Recent Initiatives

  14.7. Zoetis

  14.7.1. Company Overview

  14.7.2. Product Offerings

  14.7.3. Financial Performance

  14.7.4. Recent Initiatives

  14.8. Nutreco N.V.

  14.8.1. Company Overview

  14.8.2. Product Offerings

  14.8.3. Financial Performance

  14.8.4. Recent Initiatives

  14.9. Virbac

  14.9.1. Company Overview

  14.9.2. Product Offerings

  14.9.3. Financial Performance

  14.9.4. Recent Initiatives

  14.10. Vetquinol S.A.

  14.10.1. Company Overview

  14.10.2. Product Offerings

  14.10.3. Financial Performance

  14.10.4. Recent Initiatives

  Chapter 15. Research Methodology

  15.1. Primary Research

  15.2. Secondary Research

  15.3. Assumptions

  Chapter 16. Appendix

  16.1. About Us

  16.2. Glossary of Terms